PDL BioPharma Regroups, Piece by Piece
620824
The company still brings in plenty of money, despite selling off assets.
685744
The Medicines Company reacquires its own drug.
129442
Dr. Marcia Angell, a pathologist and former editor of The New England Journal of Medicine, is taking on the American pharmaceutical industry.
681845
The pharmaceutical giant signs another collaborative research agreement with the small-cap company.
356950
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck unveiled a   $13.3-billion deal to buy Europe's top biotech firm Serono, and   Denmark's Nycomed won the drugs unit of Altana.
632263
Late-stage drugs are crucial for a company beset with patent losses.
66523
Drug-coated stent maker Boston Scientific rebounds from recall with strong growth.
455403
The biopharma announces a dramatic shift following the failure of its lead drug.
215617
It moves manufacturing back to India and moves forward with OTC generic drugs.
438501
Here's what a newly approved drug looks like.
531621
Schering gets an expanded label and begins marketing another drug overseas.
423754
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck MRCG.DE   unveiled a $13.3-billion deal to buy Europe's top biotech firm   Serono SEO.VX, and Denmark's Nycomed won the drugs unit of   Altana ALTG.DE.
75091
The world's largest generics maker continues to post strong growth by bedeviling Big Pharma.
507775
By Tricia Bishop, The Baltimore Sun  Dec. 14--One of MedImmune Inc.'s major shareholders is urging the state's flagship biotech to put itself up for sale, suggesting management hasn't made the most from its assets, which include four products on the market and about 40 in the pipeline.
268759
The larger pharmaceutical drops out of daclizumab development.
296490
The small pharmaceutical firm signs another big deal.
583937
BAYER has formed an alliance for its struggling pharmaceuticals business with American drug-maker Schering-Plough. Drugs and chemicals group Bayer, which is in the midst of restructuring its business, said